Bavencio Injection
Marketer
Merck Ltd
Salt Composition
Avelumab (200mg)
Overview Bavencio Injection
Avelumab (Bavencio Injection) treats advanced or metastatic urinary bladder cancer in adults and children over 12. This medication bolsters the body's natural defenses to combat cancer growth, administered intravenously by a healthcare professional. To maximize efficacy, complete the prescribed treatment regimen; do not prematurely stop even if symptoms improve. Common, typically mild and transient, side effects include fatigue, nausea, diarrhea, reduced appetite, and muscle aches. Persistent or worsening side effects should be reported to your physician. Prior to treatment, inform your doctor of any prior allergic reactions to medications, and existing heart, kidney, or liver conditions. Disclose all other medications you are currently taking due to potential drug interactions. Pregnant or breastfeeding individuals should seek medical counsel before commencing treatment. A patient support/assistance program, facilitated by Tata 1mg, is accessible in India. Contact your doctor or call (1800-102-1618) for further information.
Primary Ingredients of Bavencio Injection
No text was provided to rewrite. Please provide the text you wish to have rephrased.
Uses of Bavencio Injection
Managing urinary bladder neoplasms
Major Benefits of Bavencio Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Bavencio Injection:
- Fatigue
- Musculoskeletal (bone, muscle or joint) pain
- Diarrhea
- Nausea
- Infusion site reaction
- Rash
- Decreased appetite
- Peripheral edema
- Urinary tract infection
- High blood pressure
- Mucositis
- Hand-foot syndrome
- Voice change
- Decreased level of thyroid hormones
- Liver toxicity
- Coughing up blood
- Breathlessness
- Abdominal pain
- Headache
How to use Bavencio Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Bavencio Injection works:
Bavencio, administered via injection, is an immunotherapy agent. Its mechanism involves stimulating the body's natural defenses to combat cancerous growths. The active component, avelumab, selectively binds to and inhibits PD-L1, a protein expressed on some immune cells. This inhibition unleashes the immune system's ability to identify and destroy cancer cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Bavencio Injection's interaction with alcohol is undefined; therefore, seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Bavencio Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the benefits against potential risks prior to prescribing. Seek medical advice.
Breast feedingCAUTION
Use of Bavencio Injection while breastfeeding requires careful consideration. Mothers should discontinue breastfeeding throughout treatment and until the medication is fully cleared from their system.
DrivingSAFE
Driving ability is typically unaffected by Bavencio Injection.
KidneySAFE IF PRESCRIBED
In patients with kidney impairment, Bavencio Injection is considered safe and requires no dosage modification.
LiverSAFE IF PRESCRIBED
Bavencio Injection poses no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Bavencio Injection :
Omit a Bavencio Injection dose? Seek your physician's advice.
Facts to Know About Bavencio Injection
| Label | Value |
|---|---|
| Chemical Type | Short Chains of Amino Acids |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | Other anticancer agents |
3,018 People bought this recently